Emetic risk of carboplatin plus pemetrexed is higher than that of carboplatin plus paclitaxel in patients with lung cancer: A propensity score-matched analysis
Matsuo, K., Shimokawa, M., Hayashi, T., Iihara, H., Nakano, T., Imakyure, O., Egawa, T.
Published in Annals of oncology (01.11.2019)
Published in Annals of oncology (01.11.2019)
Get full text
Journal Article